BRAF and colorectal carcinoma: Complementing these findings, Mu et al. reported that radioresistant BRAF-mutant CRC organoids mirrored postoperative tumor persistence, while in vitro synergy between 5-FU and radiation paralleled clinical chemoradiation efficacy—together establishing PDOs as a predictive tool for tailoring radiation-based strategies in CRC [55].